乳腺癌转移抑制基因1抑制肿瘤转移的作用机制

国际肿瘤学杂志››2016,Vol. 43››Issue (8): 619-621.doi:10.3760/cma.j.issn.1673-422X.2016.08.014

乳腺癌转移抑制基因1抑制肿瘤转移的作用机制

毛莉,崔彩萍,张晶,周萍

730000 兰州，甘肃省第二人民医院妇产科

出版日期:2016-08-08发布日期:2016-07-05
通讯作者:毛莉，Email： maryreylzh@126.com E-mail:maryreylzh@126.com
基金资助:

甘肃省卫生行业科研计划（GWGL2014-82）

Mechanism of breast cancer metastasis suppressor gene 1 inhibiting tumor metastasis

Mao Li, Cui Caiping, Zhang Jing, Zhou Ping

Department of Obstetrics and Gynecology, Second People′s Hospital of Gansu Province, Lanzhou 730000, China

Online:2016-08-08Published:2016-07-05
Contact:Mao Li, Email: maryreylzh@126.com E-mail:maryreylzh@126.com
Supported by:

Health Industry Scientific Research Plan of Gansu Province (GWGL2014-82)

摘要/Abstract

摘要：乳腺癌转移抑制基因1（BRMS1）在多种恶性肿瘤细胞中表达降低或缺失，具有明显降低癌细胞侵袭和转移的作用。BRMS1基因通过磷酸肌醇信号及核转录因子-κB（NF-κB）信号通路等调节基因转录和蛋白翻译，还可与mSin3组蛋白去乙酰化酶（HDAC）复合体、雌激素受体等蛋白相互作用、修复细胞间隙通讯等途径抑制肿瘤细胞的侵袭及转移。BRMS1基因将可能成为有效抑制肿瘤转移基因治疗的新靶点。

关键词:基因,肿瘤,肿瘤转移,乳腺癌转移抑制基因1,抑制作用

Abstract:Breast cancer metastasis suppressor gene 1(BRMS1) significantly reduces the invasion and metastasis of cancer cells. BRMS1 gene expression is decreased or deleted in the cells of various malignant tumors. BRMS1 gene can inhibit tumor cells invasion and metastasis by means of regulating gene transcription and protein translation by phosphoinositide signaling and nuclear factor-κB (NF-κB) signaling pathways, repairing intercellular communication and interacting with the mSin3histone deacetylase (HDAC) complex, estrogen receptor and other proteins. BRMS1 gene may be a new target for the gene treatment of tumor metastasis.

Key words:Gene,neoplasm,Tumor metastasis,Breast cancer metastasis suppressor gene 1,Inhibiting effect

毛莉,崔彩萍,张晶,周萍. 乳腺癌转移抑制基因1抑制肿瘤转移的作用机制[J]. 国际肿瘤学杂志, 2016, 43(8): 619-621.

Mao Li, Cui Caiping, Zhang Jing, Zhou Ping. Mechanism of breast cancer metastasis suppressor gene 1 inhibiting tumor metastasis[J]. Journal of International Oncology, 2016, 43(8): 619-621.

参考文献

［1］ Hedley BD, Vaidya KS, Phadke P, et al. BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation［J］. Clin Exp Metastasis, 2008, 25(7): 727-740. DOI： 10.1007/s10585-008-9184-0. ［2］ Wu Y, Mcewen GD, Harihar S, et al. BRMS1 expression alters the ultrastructural, biomechanical and biochemical properties of MDA-MB-435 human breast carcinoma cells: an AFM and Raman microspectroscopy study［J］. Cancer Lett, 2010, 293(1): 82-91. DOI： 10.1016/j.canlet.2009.12.016. ［3］ Wu Y, Jiang W, Wang Y, et al. Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression［J］. PLoS One, 2012, 7(8): e42976. DOI： 10.1371/journal.pone.0042976. ［4］ You J, He X, Ding H, et al. BRMS1 regulates apoptosis in nonsmall cell lung cancer cells［J］. Cell Biochem Biophys, 2015, 71(1): 465-472. DOI： 10.1007/s12013-014-0226-8. ［5］ Vaidya KS, Harihar S, Phadke PA, et al. Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling［J］. J Biol Chem, 2008, 283(42): 28354-28360. DOI： 10.1074/jbc.M710068200. ［6］ Liu Y, Mayo MW, Xiao A, et al. Loss of BRMS1 promotes a mesenchymal phenotype through NF-κBdependent regulation of Twist1［J］. Mol Cell Biol, 2015, 35(1): 303-317. DOI： 10.1128/MCB.00869-14. ［7］ Mei P, Bai J, Shi M, et al. BRMS1 suppresses glioma progression by regulating invasion, migration and adhesion of glioma cells［J］. PLoS One, 2014, 9(5): e98544. DOI： 10.1371/journal.pone.0098544. ［8］ Xing WJ, Liao XH, Wang N, et al. MRTF-A and STAT3 promote MDA-MB-231 cell migration via hypermethylating BRSM1［J］. IUBMB Life, 2015, 67(3): 202-217. DOI： 10.1002/iub.1362. ［9］ Slipicevic A, Holm R, Emilsen E, et al. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased diseasefree survival［J］. BMC Cancer, 2012, 12: 73. DOI： 10.1186/1471-2407-12-73. ［10］ Hurst DR. Metastasis suppression by BRMS1 associated with SIN3 chromatin remodeling complexes［J］. Cancer Metastasis Rev, 2012, 31(3/4): 641651. DOI: 10.1007/s10555-012-9363-y. ［11］ Gong C, Qu S, Lv XB, et al. BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10［J］. Nat Commun, 2014, 5: 5406. DOI： 10.1038/ncomms6406. ［12］ Roesley SN, Suryadinata R, Morrish E, et al. Cyclindependent kinasemediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration［J］. Cell Cycle, 2016, 15(1): 137-151. DOI： 10.1080/15384101.2015.1121328. ［13］ Edmonds MD, Hurst DR, Vaidya KS, et al. Breast cancer metastasis suppressor 1 coordinately regulates metastasisassociated microRNA expression［J］. Int J Cancer, 2009, 125(8): 1778-1785. DOI： 10.1002/ijc.24616. ［14］ Bodenstine TM, Vaidya KS, Ismail A, et al. Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition［J］. Cancer Res, 2010, 70(23): 10002-10011. DOI： 10.1158/0008-5472.CAN-10-2606. ［15］ Ma H, Gollahon LS. ERα mediates estrogeninduced expression of the breast cancer metastasis suppressor gene BRMS1［J］. Int J Mol Sci, 2016, 17(2): 10. DOI： 10.3390/ijms17020158. ［16］ Wu J, Wang Y, Qiao X, et al. Cloning and characterization of a novel human BRMS1 transcript variant in hepatocellular carcinoma cells［J］. Cancer Lett, 2013, 337(2): 266-275. DOI： 10.1016/j.canlet.2013.04.030. ［17］ Kramer D, Schn M, Bayerlová M, et al. A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity［J］. Cell death disease, 2015, 6: e1634. DOI： 10.1038/cddis.2015.17. ［18］ Balgkouranidou I, Chimonidou M, Milaki G, et al. Breast cancer metastasis suppressor1 promoter methylation in cellfree DNA provides prognostic information in non-small cell lung cancer［J］. Br J Cancer, 2014, 110(8): 2054-2062. DOI： 10.1038/bjc.2014.104.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.